OC and setipip news

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sdsurfin
    Senior Member
    • Sep 2013
    • 702

    No news yet. Will keep you posted. Look to follicept for a possible near term option. Les keep our fingers crossed

    Comment

    • Popeyes
      Junior Member
      • Apr 2015
      • 11

      How would we know what is an effective does orally?

      Comment

      • DrakeDuck
        Junior Member
        • Sep 2014
        • 5

        Hey Hell,

        I came across a thread on ************ about a setipiprant buy, and it looked like maybe you got it on it. Did you ever get any, and are you currently testing? Sorry if I missed any threads where you may have discussed this...I looked.

        Comment

        • Farkhairloss
          Junior Member
          • May 2015
          • 21

          Any more news on whether Kane or anyone else is started manufacturing SM04554 or setipiprant?

          Comment

          • charlie76761
            Member
            • Oct 2014
            • 60

            Originally posted by Farkhairloss
            Any more news on whether Kane or anyone else is started manufacturing SM04554 or setipiprant?
            See earlier posts listed on my profile re SM: he needs more info on the compound - no one is 100% sure which molecule it is as there are a few wrt patencies by the development company

            Comment

            • lifelonglearning
              Member
              • Jun 2014
              • 69

              http://www.thestreet.com/video/13156...thera-ceo.html skip to 2 minutes confirms its oral drug

              Comment

              • lifelonglearning
                Member
                • Jun 2014
                • 69

                In February 2015, the Company entered into a licensing arrangement with Actelion and University of Pennsylvania pursuant to which it obtained exclusive worldwide rights to setipiprant, a clinical-stage selective and potent oral antagonist to the prostaglandin D 2 (PGD 2 ) receptor and exclusive worldwide rights to certain patent rights owned by the University of Pennsylvania covering the use of PGD 2 receptor antagonists for the treatment of hair loss. As part of the agreement, Actelion received an initial payment of $1,500,000 and will be eligible to receive up to an additional $25,500,000 in potential development and regulatory milestones, as well as royalties on sales if setipiprant is successfully commercialized. University of Pennsylvania will receive an initial payment of $100,000, certain annual license maintenance fees beginning in the third year of the agreement, as well as is eligible to receive up to $4,125,000 in milestone payments and royalties on sales of products commercialized under the patents provided for in the agreement.

                Comment

                • GSD
                  Member
                  • Apr 2015
                  • 75

                  Originally posted by lifelonglearning
                  http://www.thestreet.com/video/13156...thera-ceo.html skip to 2 minutes confirms its oral drug
                  "Only prevention"

                  Comment

                  • Swooping
                    Senior Member
                    • May 2014
                    • 794

                    Originally posted by lifelonglearning
                    In February 2015, the Company entered into a licensing arrangement with Actelion and University of Pennsylvania pursuant to which it obtained exclusive worldwide rights to setipiprant, a clinical-stage selective and potent oral antagonist to the prostaglandin D 2 (PGD 2 ) receptor and exclusive worldwide rights to certain patent rights owned by the University of Pennsylvania covering the use of PGD 2 receptor antagonists for the treatment of hair loss. As part of the agreement, Actelion received an initial payment of $1,500,000 and will be eligible to receive up to an additional $25,500,000 in potential development and regulatory milestones, as well as royalties on sales if setipiprant is successfully commercialized. University of Pennsylvania will receive an initial payment of $100,000, certain annual license maintenance fees beginning in the third year of the agreement, as well as is eligible to receive up to $4,125,000 in milestone payments and royalties on sales of products commercialized under the patents provided for in the agreement.
                    As expected.. Pocket change. Actelion really wanted to get rid of that compound it seems. Going to be interesting to see what the trial will bring.

                    Comment

                    • mlamber5
                      Member
                      • Mar 2015
                      • 67

                      I think they have to say "only prevention." Cots himself has said he doesn't know if it will regrow hair in areas that already have hair loss or not. We already have a pretty damn good prevention drug on the market (finasteride). It very well may do more than just prevent hair loss/further hair loss.

                      Comment

                      • KO1
                        Senior Member
                        • Jan 2012
                        • 805

                        Originally posted by GSD
                        "Only prevention"
                        Told you so.

                        Comment

                        • FearTheLoss
                          Senior Member
                          • Dec 2012
                          • 1581

                          SD whatever happened to TLR, have you heard from them lately?

                          Comment

                          • burtandernie
                            Senior Member
                            • Nov 2012
                            • 1563

                            I wonder how well this will work for prevention. As good as fin is its still not perfect and doesnt help some men at all. So maybe this will help a larger percent and maybe even work better at preventing hair loss at front/temples

                            Comment

                            • buck
                              Junior Member
                              • May 2014
                              • 20

                              I e-mailed Kane about OC. He replied that a new batch will be ready in about 2-3 weeks and that the cost was $200/ gram. Does that sound right? At 1% every day or 2% every other day, that's over a three month supply.

                              Comment

                              • champpy
                                Senior Member
                                • Apr 2015
                                • 336

                                Is OC supposed to be superior to RU? Sorry im very new to these treatments

                                Comment

                                Working...